<https://rdf.molmedb.upol.cz/reference/ref2095> <http://purl.org/dc/terms/bibliographicCitation> "Barber CG, Blakemore DC, Chiva JY, Eastwood RL, Middleton DS, Paradowski KA.: 1-Amido-1-phenyl-3-piperidinylbutanes--CCR5 antagonists for the treatment of HIV: part 2. Bioorg Med Chem Lett, Volume 19 (5), 2009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM17095.1>;
	<http://purl.org/ontology/bibo/pmid> "19185490"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM17095>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2009.01.008"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>,
		<https://identifiers.org/molmedb/MM475729> .
<https://rdf.molmedb.upol.cz/interaction/int1028577> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .
<https://rdf.molmedb.upol.cz/interaction/int977714> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .
<https://rdf.molmedb.upol.cz/interaction/int977610> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .
<https://rdf.molmedb.upol.cz/interaction/int1028578> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .
<https://rdf.molmedb.upol.cz/interaction/int976982> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .
<https://rdf.molmedb.upol.cz/interaction/int977198> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref2095> .